中国现代医学杂志2024,Vol.34Issue(19) :51-55.DOI:10.3969/j.issn.1005-8982.2024.19.008

肠道微生物群与脓毒症心肌病相互作用的研究进展

Advances in research on gut microbiota in sepsis-induced cardiomyopathy

牟青松 任香凝 陆金帅 张静
中国现代医学杂志2024,Vol.34Issue(19) :51-55.DOI:10.3969/j.issn.1005-8982.2024.19.008

肠道微生物群与脓毒症心肌病相互作用的研究进展

Advances in research on gut microbiota in sepsis-induced cardiomyopathy

牟青松 1任香凝 1陆金帅 1张静1
扫码查看

作者信息

  • 1. 新疆维吾尔自治区人民医院,新疆急救中心,新疆乌鲁木齐 830001
  • 折叠

摘要

脓毒症心肌病(SICM)是脓毒症的常见并发症,其发病机制尚不完全清楚.目前大量研究证明肠道微生态与多种心血管疾病相关,而少有研究报道肠道菌群对SICM的影响.近年来,有研究发现,除了已知的机制外,肠道微生物组失衡、黏膜屏障损伤、微生物易位、代谢失调、线粒体功能障碍及炎症反应可能通过肠-心轴或肠-肾-心轴影响SICM.该综述主要探讨了脓毒症期间肠道菌群与SICM的潜在联系,更好地了解这一机制将有助于改善脓毒症的治疗,并使脓毒症患者获得更好的预后.

Abstract

Sepsis-induced cardiomyopathy(SICM)represents a frequent sepsis complication,with its underlying mechanisms remain incompletely understood.Extensive research has established the gut microbiota's association with various cardiovascular diseases;however,insights into its impact on SICM remain limited.Recent investigations beyond established mechanisms have identified potential influences on SICM through the gut-heart or gut-kidney-heart axis,including dysbiosis of the gut microbiome,impairment of the mucosal barrier,microbial translocation,metabolic dysregulation,mitochondrial dysfunction,and inflammatory responses.This review aims to delve into the potential interplay between gut microbiota alterations during sepsis and SICM.Enhancing our understanding of these connections could pave the way for improved therapeutic approaches to sepsis and better prognoses for affected individuals.

关键词

脓毒症/脓毒症心肌病/肠道菌群/微生物-肠-心轴

Key words

sepsis/sepsis-induced cardiomyopathy/gut microbiota/microbiota-gut-heart axis

引用本文复制引用

基金项目

新疆维吾尔自治区自然科学基金(2022D01C117)

出版年

2024
中国现代医学杂志
中南大学,卫生部肝胆肠外科研究中心

中国现代医学杂志

CSTPCD
影响因子:0.927
ISSN:1005-8982
段落导航相关论文